Startup profile · funding coverage
Baba funding, valuation and investors
Care coordination for patients and families, combining human advocates, clinicians and AI-supported administrative work.
Keep track of Baba
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series A
$40M · October 20, 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$47M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a · New York, United States
Investors in latest funding
Lead: FirstMark Capital
Other: CVS Health Ventures , Valtruis , General Catalyst , Genius Ventures , Ground Up Ventures
Overview
Baba supports patients and families navigating Medicare and Medicaid, and works with health plans. It announced a $40M Series A on October 20, 2026, led by FirstMark Capital. Valuation and revenue were undisclosed. Its dedicated care teams use AI for administrative work while people remain responsible for coordination. Sources: https://www.callbaba.com/updates/baba-raises-40m-series-a/ and https://firstmark.com/story/ai-native-care-leading-babas-40m-series-a/ .
Why Baba is interesting
Baba targets the labor behind referrals, insurance calls and follow-through. Its economic test is whether automation reduces work per completed task while maintaining human oversight. The company reports $47M cumulative funding; the disclosed seed lower bound and Series A sum to more than $46.5M, not an exact lifetime total.
Product & use cases
Advocates coordinate referrals, provider contact, transportation and insurance paperwork. Baba says it bills insurance first, with plan-specific patient cost-sharing possible; published sample bills are illustrative rather than average customer prices. Source: https://www.callbaba.com/payment-responsibility/ (checked October 25, 2026).
Funding history (newest first)
Series A
2026-10-20 $40M- FirstMark Capital (lead)
- CVS Health Ventures (participant)
- Valtruis (participant)
- General Catalyst (participant)
- Genius Ventures (participant)
- Ground Up Ventures (participant)
Source: Read source · callbaba.com
Seed
2026-02-25 More than $6.5M- General Catalyst (lead)
- Genius Ventures (participant)
- Soma Capital (participant)
- Ground Up Ventures (participant)
- Triedge Investments (participant)
- Jordi Hays (participant)
- Kareem Amin (participant)
Source: Read source · callbaba.com
Investors in our directory
Funds linked from Baba's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
The relevant substitutes include families' own coordination work and existing health-plan or provider support. Capital raised does not establish superior outcomes or lower delivery costs.
-
Solace Health direct
Patient-advocacy marketplace; related buyer need, with its own advocate network and payment arrangements.
-
Rightway adjacent
Employer-focused pharmacy-benefit management and care navigation; a different buyer and financing stage.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Baba's financing or category context.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.